MedTrace Logo

Observational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin

NCT00670722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6500

Last updated 2016-10-28

No results posted yet for this study

Summary

This study is conducted in Europe. An observational study evaluating the blood glucose control in patients using a modern insulin: NovoRapid®, NovoMix® 30 or Levemir® for treatment of Type 2 diabetes mellitus in Czech Republic.

Conditions

Interventions

DRUG

insulin aspart

Intervention at the discretion of the physician

DRUG

insulin detemir

Intervention at the discretion of the physician

DRUG

biphasic insulin aspart 30

Intervention at the discretion of the physician

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00670722 on ClinicalTrials.gov